Employees: 12 (2023.0)Legal category: 5485Size: PMECreation date: 1995-03-01 (31 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: ORLEANS (45100), Loiret
S.E.L.A.R.L. PHARMACIE DE LA CIGOGNE : revenue, balance sheet and financial ratios
S.E.L.A.R.L. PHARMACIE DE LA CIGOGNE is a French company
founded 31 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in ORLEANS (45100),
this company of category PME
shows in 2022 a revenue of 8.5 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - S.E.L.A.R.L. PHARMACIE DE LA CIGOGNE (SIREN 400647160)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
8 484 573 €
N/C
7 283 464 €
N/C
N/C
N/C
N/C
Net income
230 758 €
316 450 €
613 488 €
415 740 €
286 637 €
312 936 €
293 595 €
269 372 €
262 692 €
EBITDA
N/C
N/C
875 093 €
N/C
485 105 €
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
7.2%
N/C
3.9%
N/C
N/C
N/C
N/C
Revenue and income statement
In 2024, S.E.L.A.R.L. PHARMACIE DE LA CIGOGNE generates positive net income of 231 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 263 k€ -> 231 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
230 758 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 185%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 29%. The balance between equity and debt is satisfactory.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
184.641%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
29.494%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution S.E.L.A.R.L. PHARMACIE DE LA CIGOGNE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
18.167
26.815
21.781
16.237
17.436
550.077
277.025
215.034
184.641
Financial autonomy
71.186
66.795
68.795
72.989
73.402
12.913
22.874
26.525
29.494
Repayment capacity
None
None
None
None
1.722
None
5.47
None
None
Cash flow / Revenue
None%
None%
None%
None%
5.137%
None%
7.71%
None%
None%
Sector positioning
Debt ratio
184.642024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Average
In 2024, the debt ratio of S.E.L.A.R.L. PHARMACIE DE... (184.64) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
29.49%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Average
In 2024, the financial autonomy of S.E.L.A.R.L. PHARMACIE DE... (29.5%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Repayment capacity
5.47 years2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Average
In 2022, the repayment capacity of S.E.L.A.R.L. PHARMACIE DE... (5.47) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 234.32. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
234.319
Liquidity indicators evolution S.E.L.A.R.L. PHARMACIE DE LA CIGOGNE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
168.946
195.717
217.583
258.305
329.678
266.455
277.465
260.133
234.319
Interest coverage
None
None
None
None
1.077
None
1.95
None
None
Sector positioning
Liquidity ratio
234.322024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Good-8 pts over 3 years
In 2024, the liquidity ratio of S.E.L.A.R.L. PHARMACIE DE... (234.32) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Interest coverage
1.95x2022
2022
Q1: 0.74x
Med: 2.5x
Q3: 5.15x
Average
In 2022, the interest coverage of S.E.L.A.R.L. PHARMACIE DE... (1.9x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution S.E.L.A.R.L. PHARMACIE DE LA CIGOGNE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Operating WCR
0 €
0 €
0 €
0 €
1 207 817 €
0 €
1 800 766 €
0 €
0 €
Inventory turnover (days)
0
0
0
0
50
0
51
0
0
Customer payment term (days)
0
0
0
0
4
0
9
0
0
Supplier payment term (days)
0
0
0
0
34
0
35
0
0
Positioning of S.E.L.A.R.L. PHARMACIE DE LA CIGOGNE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of S.E.L.A.R.L. PHARMACIE DE LA CIGOGNE is estimated at
3 221 552 €
(range 2 243 438€ - 4 819 626€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
2243k€3221k€4819k€
3 221 552 €Range: 2 243 438€ - 4 819 626€
NAF 5 année 2024
Valuation method used
Net Income Multiple
230 758 €
×
14.0x
=3 221 552 €
Range: 2 243 438€ - 4 819 627€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare S.E.L.A.R.L. PHARMACIE DE LA CIGOGNE with other companies in the same sector:
Frequently asked questions about S.E.L.A.R.L. PHARMACIE DE LA CIGOGNE
What is the revenue of S.E.L.A.R.L. PHARMACIE DE LA CIGOGNE ?
The revenue of S.E.L.A.R.L. PHARMACIE DE LA CIGOGNE in 2022 is 8.5 M€.
Is S.E.L.A.R.L. PHARMACIE DE LA CIGOGNE profitable?
Yes, S.E.L.A.R.L. PHARMACIE DE LA CIGOGNE generated a net profit of 231 k€ in 2024.
Where is the headquarters of S.E.L.A.R.L. PHARMACIE DE LA CIGOGNE ?
The headquarters of S.E.L.A.R.L. PHARMACIE DE LA CIGOGNE is located in ORLEANS (45100), in the department Loiret.
Where to find the tax return of S.E.L.A.R.L. PHARMACIE DE LA CIGOGNE ?
The tax return of S.E.L.A.R.L. PHARMACIE DE LA CIGOGNE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does S.E.L.A.R.L. PHARMACIE DE LA CIGOGNE operate?
S.E.L.A.R.L. PHARMACIE DE LA CIGOGNE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart